Urinary estrogen and progesterone metabolite concentrations in menstrual cycles of fertile women with non-conception, early pregnancy loss or clinical pregnancy

Harvard University, Cambridge, Massachusetts, United States
Human Reproduction (Impact Factor: 4.57). 10/2006; 21(9):2272-80. DOI: 10.1093/humrep/del187
Source: PubMed


Knowledge is limited of how estrogen and progesterone variability in fertile women are associated with achieving pregnancy.
From 1996 to 1998, we enrolled 347 textile workers without hormone treatment in Anhui, China, who provided daily urine and data upon stopping contraception for up to 1 year until clinical pregnancy. Urinary hCG was assayed to detect conception and early pregnancy losses. We compared urinary concentrations of estrone conjugates (E(1)C) and pregnanediol-3-glucuronide (PdG) in 266 clinical pregnancies, 63 early pregnancy losses and 272 non-conception cycles from 347 women and also in 94 clinical pregnancy and 94 non-conception cycles from the same women.
Using generalized estimating equations and relative to 266 clinical pregnancy cycles, log(E(1)C) was lower in 272 non-conception cycles [beta = -0.3 ng/mg creatinine (Cr); SE = 0.1; P < 0.0001]. On average, daily E(1)C was 18 ng/mg Cr lower in non-conception cycles than in clinical pregnancy cycles. Relative to 94 clinical pregnancy cycles, log(E(1)C) was lower in 94 non-conception cycles (beta = -0.4 ng/mg Cr; SE = 0.1; P < 0.0001) from the same women (average difference in daily E(1)C was 20 ng/mg Cr). The odds of E(1)C less than the 10th percentile (<30 ng/mg Cr) were higher in early pregnancy loss cycles [odds ratio (OR) = 4.8; P = 0.0027] than in clinical pregnancy cycles in the early luteal phase. Compared with clinical pregnancy cycles, log(PdG) concentrations were lower in non-conception cycles during the follicular phase, but this analysis lacked power for multiple testing.
Estrogen concentrations varied from cycle to cycle, and higher estrogen was associated with achieving clinical pregnancy.

Download full-text


Available from: Xiaobin Wang, Oct 03, 2014
    • "Li and colleagues (2001) reported that conception cycles had higher serum estradiol on the day that FSH peaked, but total urinary E2 metabolite levels in conception and nonconception cycles were similar. Likewise , urinary estrogen levels did not differ once other hormonal confounders were controlled (Baird et al., 1999), but other studies have reported higher estrogen levels in conception compared to nonconception cycles (Lipson & Ellison, 1996; Stewart et al., 1993; Venners et al., 2006). As noted earlier, findings from Project REPA (Vitzthum et al., 2004) refute the hypothesis that variation in steroid levels across populations is necessarily associated with variation in fecundity (Ellison et al., 1993; Ellison, 1994; Lipson, 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Some studies have reported that birth size is a risk factor for breast cancer, but the reasons for this observation are unknown. Ovarian hormone concentrations may be a link between birth size and breast cancer, but the few tests of this hypothesis are inconsistent, perhaps because of differences in sample composition, inclusion of anovulatory cycles, or use of one hormonal measurement per woman. We present results from the first study to use daily hormonal measurements throughout a woman's complete ovulatory cycle to test the hypothesized relationship between birth size and adult progesterone concentrations. We used a study sample and accompanying data set previously obtained for another research project in which we had collected daily urine samples from 63 healthy premenopausal women throughout a menstrual cycle. Multivariate regression was used to test for trends of individual progesterone indices (from 55 ovulatory cycles) with birth weight or ponderal index, while controlling for age, adult BMI, and age at menarche. Our main finding was that neither birth weight nor ponderal index was associated with biologically significant variation in luteal progesterone indices; the best-estimated effect sizes of birth size on these progesterone indices were small (3.7-10.2 %). BMI was the only significant predictor of mean peak urinary progesterone, but it explained <6 % of the variance. Our findings, in light of what is currently known regarding associations of breast cancer risk with birth size and adult size, suggest that environmental factors (particularly those that vary by socioeconomic status and affect growth) may underlie associations between birth size and cancer risks without there being any association of birth size with adult ovarian hormone concentrations.
    Hormones and Cancer 04/2015; 6(4). DOI:10.1007/s12672-015-0221-6 · 0.02 Impact Factor
  • Source
    • "Levels of estrogen peak in the ovulatory (or follicular) phase just before ovulation (day 13 of a 28-day cycle; Jones 1997; Roney and Simmons 2013) and drop back to baseline a few days after ovulation (Venners et al. 2006). Because ovulation is the only time women's sexual behavior can result in pregnancy, the rise in estrogen near ovulation has been found to influence women's attitudes, preferences, and behaviors in specific ways (Roney and Simmons 2013; Thornhill and Gangestad 2008; Venners et al. 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous research finds that ovulation—the time each month when women are most fertile—can shift women’s mating psychology and increase their desire for new options in men. However, might ovulation also increase women’s desire for new products? Four studies find that women select a greater number of unique options from consumer product sets at high fertility. This effect is especially strong for women in committed relationships. Additional findings show that the fertility shift in desire for variety in products is driven by the fertility shift in desire for new options in men activating a variety-seeking mind-set. Subsequently, loyalty to a romantic partner, whether manipulated or measured, moderated the effect of fertility on consumer variety seeking. This research contributes to the literature by revealing when, why, and how fertility influences desire for variety in consumer choice and highlights the mating motives that underlie this effect.
    Journal of Consumer Research 11/2014; 41(6):000-000. DOI:10.1086/679652 · 3.10 Impact Factor
  • Source
    • "One strategy for testing whether attractiveness judgments are generated by specialized preference mechanisms is to assess whether such judgments correlate with biological markers of health or fecundity, since positive correlations would be difficult to explain if attractiveness standards were culturally arbitrary. Women's concentrations of estradiol and progesterone appear to act as biological markers of fecundity given evidence that these concentrations are positively correlated with conception probabilities (see Baird et al., 1999; Lipson & Ellison, 1996; Stewart et al., 1993; Venners et al., 2006). Jasienska, Ziomkiewicz, Ellison, Lipson, and Thune (2004) demonstrated that low WHR and large breast size predicted higher concentrations of these ovarian hormones across broad regions of the menstrual cycle, suggesting that these body shape characteristics may be valid cues of fecundity, at least within their sample of well-nourished Polish women. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Does women’s body attractiveness predict indices of reproductive capacity? Prior research has provided evidence that large breast size and low waist-to-hip ratio (WHR) are positively associated with women’s estrogen and progesterone concentrations, but no previous studies appear to have directly tested whether ratings of women's body attractiveness are predicted by higher concentrations of ovarian hormones measured across broad regions of the menstrual cycle. Here, we collected daily saliva samples across 1–2 menstrual cycles from a sample of young women; assayed the samples for estradiol, progesterone, and testosterone; obtained anthropometric measurements of the women’s bodies; and also obtained attractiveness ratings of the women’s bodies from photographs of them taken in standardized clothing with faces obscured. Contrary to previous research, mean hormone concentrations were uncorrelated with breast size and WHR. Body mass index (BMI) was a very strong negative predictor of body attractiveness ratings, similar to previous findings. Zero-order associations between women’s mean hormone concentrations and mean attractiveness ratings were not significant; however, after controlling for BMI, attractiveness ratings were independently and positively associated with both estradiol and testosterone concentrations. Discussion focuses on the implications of these findings for whether attractiveness assessment mechanisms are specialized for the detection of cues of differential fecundity in young women’s bodies.
    Evolution and Human Behavior 05/2014; 35(3). DOI:10.1016/j.evolhumbehav.2014.01.001 · 3.13 Impact Factor
Show more